End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15,560 KRW | +0.19% | +3.25% | -14.32% |
2023 | Il Dong Pharmaceutical Eyes Approval for to Manufacture Japan's COVID-19 Treatment in South Korea | MT |
2023 | Il Dong Pharmaceutical Introduces New R&D Unit Yunovia | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.32% | 317M | |
+26.15% | 681B | |
+21.85% | 556B | |
-5.11% | 361B | |
+17.41% | 325B | |
+5.01% | 285B | |
+13.68% | 235B | |
+3.65% | 199B | |
-11.12% | 189B | |
-4.08% | 157B |
- Stock Market
- Equities
- A249420 Stock
- News Ildong Pharmaceutical Co., Ltd.
- Il Dong Pharmaceutical Starts Clinical Trial of COVID-19 Drug